Literature DB >> 11779930

Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view.

Kennedy R Lees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11779930

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  8 in total

Review 1.  Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia.

Authors:  H Bart van der Worp; Peter de Haan; Erik Morrema; Cor J Kalkman
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 2.  Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies.

Authors:  Alexander G Yakovlev; Alan I Faden
Journal:  NeuroRx       Date:  2004-01

Review 3.  Optimizing functional outcome endpoints for stroke recovery studies.

Authors:  Mustafa Balkaya; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-14       Impact factor: 6.200

4.  Timely and Appropriate Administration of Inhaled Argon Provides Better Outcomes for tMCAO Mice: A Controlled, Randomized, and Double-Blind Animal Study.

Authors:  Juan He; Ke Xue; Jiayi Liu; Jin-Hua Gu; Bin Peng; Lihua Xu; Guohua Wang; Zhenglin Jiang; Xia Li; Yunfeng Zhang
Journal:  Neurocrit Care       Date:  2022-02-08       Impact factor: 3.532

5.  Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.

Authors:  Nicholas J Mulcahy; Jerard Ross; Nancy J Rothwell; Sarah A Loddick
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

Review 6.  Clinical trial design for endovascular ischemic stroke intervention.

Authors:  Osama O Zaidat; David S Liebeskind; Randall C Edgell; Catherine M Amlie-Lefond; Junaid S Kalia; Andrei V Alexandrov
Journal:  Neurology       Date:  2012-09-25       Impact factor: 9.910

7.  Pharmacokinetics of escalating doses of intravenous repinotan in healthy male volunteers.

Authors:  Roland Heinig; Michael F Böttcher
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

8.  Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat.

Authors:  Eduardo Candelario-Jalil; Noël H Mhadu; Armando González-Falcón; Michel García-Cabrera; Eduardo Muñoz; Olga Sonia León; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2005-01-18       Impact factor: 8.322
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.